Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Masimo Corp (MASI)

Masimo Corp (MASI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Masimo Corp 52 DISCOVERY IRVINE CA 92618 USA

www.masimo.com P: 949-297-7000

Description:

Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation.

Key Statistics

Overview:

Market Capitalization, $K 7,249,080
Enterprise Value, $K 7,957,780
Shares Outstanding, K 52,913
Annual Sales, $ 2,048 M
Annual Net Income, $ 81,500 K
Last Quarter Sales, $ 548,900 K
Last Quarter Net Income, $ 33,900 K
EBIT, $ 136,500 K
EBITDA, $ 236,700 K
60-Month Beta 0.99
% of Insider Shareholders 9.70%
% of Institutional Shareholders 85.96%
Float, K 47,780
% Float 90.30%
Short Volume Ratio 0.12

Growth:

1-Year Return -26.56%
3-Year Return -38.88%
5-Year Return -2.16%
5-Year Revenue Growth 138.63%
5-Year Earnings Growth 25.08%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.25 on 02/27/24
Latest Earnings Date 05/07/24 [AMC]
Earnings Per Share ttm 3.37
EPS Growth vs. Prev Qtr 98.41%
EPS Growth vs. Prev Year -5.30%
Annual Dividend Yield 0.00%
Most Recent Dividend 1.000 on 11/23/12
Dividend Payable Date 12/11/12
Dividend Payout Ratio 0.00%

MASI Ratios

Ratio
Price/Earnings ttm 40.43
Price/Earnings forward 38.82
Price/Earnings to Growth N/A
Return-on-Equity % 13.78%
Return-on-Assets % 5.98%
Profit Margin % 3.98%
Debt/Equity 0.64
Price/Sales 3.52
Price/Cash Flow 23.64
Price/Book 5.28
Book Value/Share 25.79
Interest Coverage -1.13

MASI Dividends

Date Value
11/23/12 $1.0000
12/03/10 $0.7500
03/09/10 $2.0000
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar